FDC
Back to Balance Sheet
|
FDC Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹812 Cr | ₹604 Cr | ₹469 Cr | ₹391 Cr | ₹300 Cr |
What is the latest Total Non-Current Liabilities ratio of FDC ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹812 Cr |
| Mar2024 | ₹604 Cr |
| Mar2023 | ₹469 Cr |
| Mar2022 | ₹391 Cr |
| Mar2021 | ₹300 Cr |
How is Total Non-Current Liabilities of FDC Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹812 Cr | 34.38 | |
| Mar2024 | ₹604 Cr | 28.92 | |
| Mar2023 | ₹469 Cr | 19.81 | |
| Mar2022 | ₹391 Cr | 30.55 | |
| Mar2021 | ₹300 Cr | - | |
Compare Total Non-Current Liabilities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹6,810.7 Cr | 1.5% | -3.1% | -15.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,044.0 Cr | -0.7% | 4.3% | 0.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,877.0 Cr | -0.6% | -2.6% | 6.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,042.0 Cr | 0.4% | 4.7% | 19.8% | Stock Analytics | |
| CIPLA | ₹123,060.0 Cr | -1.3% | -4.8% | 2.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,190.0 Cr | -1.1% | -3.7% | 2.5% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | 1.5% |
-3.1% |
-15.4% |
| SENSEX | 0.5% |
1.7% |
11% |
You may also like the below Video Courses